Delivery Order HHSN261201600016I-HHSN26100003
Award Date
8/11/17
Potential Completion Date
6/30/21
Potential Value
$116K
Federal Agency
National Cancer Institute
Awardee
Battelle Memorial Institute
Ultimate Awardee
Not listed
NAICS Category
541690 - Other Scientific and Technical Consulting Services
PSC Category
R499 - Support- Professional: Other
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Columbus, OH 43201, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
4
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
<p>This is a $1,784.00 firm fixed price delivery order contract awarded by the National Cancer Institute, a civilian agency, to Battelle Memorial Institute for initial administrative charges related to a pre-clinical toxicology study of a drug being developed for cancer patients. The contract is an order placed under the Toxicology of Drugs Developed for Cancer Patients indefinite-delivery indefinite-quantity (IDIQ) contract vehicle. No set-aside was used for this award.</p>
This is a cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency, to the University of Illinois. The contract is valued at $761,043.02 and is part of the larger "Toxicology of Drugs Developed for Cancer Patients" indefinite delivery/indefinite quantity (IDIQ) contract vehicle. The purpose of this award is to conduct pre-clinical toxicology studies of a drug candidate, specifically DNA methyltransferase-TdCyd, for potential use in...
This is a delivery order under the Toxicology of Drugs Developed for Cancer Patients contract vehicle, awarded by the National Cancer Institute (NCI) to Battelle Memorial Institute. The $248,269.21 cost-plus-fixed-fee contract is for a pre-clinical toxicity study to characterize the toxicity of potential anticancer compounds following multiple dose administration to rats. The contract runs from January 18, 2017 to June 30, 2018. No set-aside designation is mentioned. Battelle frequently serves...
This is a Cost Plus Fixed Fee definitive contract awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to Battelle Memorial Institute (doing business as Battelle) for $91,567,452.38. The contract is for preclinical toxicology and pharmacology services related to the development of drugs. There is no set-aside designation indicated. Battelle is a large, non-profit research and development organization that frequently provides...
This is a $14,106,772 cost plus fixed fee delivery order awarded by the National Center for Advancing Translational Sciences, a civilian agency, to Battelle Memorial Institute for validation of bioanalytical assays and IND-enabling GLP PD/PK toxicology studies in rats and dogs. The work is being performed under the Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products for Neurological-related Disorders indefinite delivery, indefinite quantity...
This is a delivery order worth $3,102 awarded by the National Cancer Institute (NCI) to Battelle Memorial Institute, a nonprofit research and development organization, for a contract orientation meeting related to preclinical pharmacology and toxicology studies. The delivery order was issued under a larger Preclinical Pharmacology and Toxicology Studies contract vehicle that runs from 2012 to 2014. The award does not have a set-aside designation. Battelle frequently partners with universities...
This is a delivery order awarded to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc., by the National Cancer Institute (NCI). The $3,323,184.00 cost-plus-fixed-fee contract is for longitudinal studies of dogs with cancer as a comparative oncology model. Leidos Biomedical Research Inc. is a Federally Funded Research and Development Center (FFRDC) contractor for NCI, providing a range of biomedical research and facilities support services. This contract has no set-aside...
This is a definitive contract valued at $69,611,517.00 awarded by the National Institutes of Health (NIH) to Battelle Memorial Institute, a nonprofit organization and manufacturer of goods, to conduct studies evaluating the toxicologic and carcinogenic potential of various substances. The contract does not have a set-aside designation. Battelle frequently partners with specialized manufacturers and technical consultants to deliver a wide range of research, engineering, testing, and information...
This is a Cost Plus Fixed Fee contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization. The $159,319,089.46 contract, which does not have a set-aside designation, is for preclinical toxicology and pharmacology studies to support Investigational New Drug (IND) applications for small molecule, biologic, and RNA therapeutic candidates across various...
This is a $712,518 Cost Plus Award Fee delivery order issued by the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) to Battelle Memorial Institute, a nonprofit research organization, under the NIAID Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery/indefinite quantity (IDIQ) contract vehicle. The contract supports pre-clinical modeling of infectious diseases. Battelle has subcontracted portions of the work to Data Sciences...